Carolyn Estes
Family · Tupelo, MSNPI 1811963127
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 250 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 19.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $2,582 and has fallen 98.7% since, to $34 in 2024. Among family clinicians in MS with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 250 payments — averaging $16.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$789
- AstraZeneca$690
- Boehringer Ingelheim$651
- Novartis$235
- United Therapeutics Corporation$231
- Harmony Biosciences LLC$206
- plus $1K from 19 others
What the payments were for
- Food & beverage$4,145100%
- Education$30%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 61 | $789 |
| AstraZeneca | 30 | $690 |
| Boehringer Ingelheim | 40 | $651 |
| Novartis | 14 | $235 |
| United Therapeutics Corporation | 14 | $231 |
| Harmony Biosciences LLC | 11 | $206 |
| Mallinckrodt Hospital Products Inc. | 14 | $205 |
| Jazz Pharmaceuticals Inc. | 8 | $194 |
| Genentech USA, Inc. | 12 | $128 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $121 |
| Regeneron Healthcare Solutions, Inc. | 6 | $120 |
| Sanofi | 7 | $111 |
| Merck | 5 | $85 |
| Insmed, Inc. | 4 | $73 |
| Mylan Specialty L.p. | 4 | $65 |
| Bayer | 3 | $47 |
| Axsome Therapeutics, Inc. | 2 | $40 |
| Gilead | 3 | $36 |
| ANI Pharmaceuticals, Inc. | 1 | $26 |
| Shionogi Inc | 1 | $24 |
| Ambu Inc. | 1 | $19 |
| Amgen | 1 | $18 |
| Pfizer | 1 | $16 |
| Grifols USA, LLC | 1 | $15 |
| Breas Medical, Inc. | 1 | $4 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FASENRA$143
- BREZTRI$143
- TRELEGY ELLIPTA$125
How this compares
$4,147 in reported general payments places this provider in the 90th percentile of 3,007 family providers in Mississippi.
Other family in Tupelo
- Jessica EatonTupelo$25K
- Lisa SandersTupelo$16K
- Amanda RobinsonTupelo$15K
- Ashley HensonTupelo$12K
- Dodie McGeeRaymond$772K
- Gina BurgeJackson$237K
- Christy DavisJackson$208K
- Maranda EversollFlowood$197K
- Dana DelaskiJackson$158K
- Kristin CarrollJackson$158K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.